A new era in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): clinical breakthroughs and challenges.
- DOI
- 10.3389/fphar.2026.1815576
- Published
- 2026-08-31
- Container
- Front Pharmacol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1815576,
title = {A new era in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): clinical breakthroughs and challenges.},
author = {You Z and Yang L and Long Y and You D and Zhao Q.},
year = {2026},
journal = {Front Pharmacol},
doi = {10.3389/fphar.2026.1815576},
url = {https://doi.org/10.3389/fphar.2026.1815576}
}RIS
TY - JOUR TI - A new era in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): clinical breakthroughs and challenges. AU - You Z AU - Yang L AU - Long Y AU - You D AU - Zhao Q. PY - 2026 JO - Front Pharmacol DO - 10.3389/fphar.2026.1815576 UR - https://doi.org/10.3389/fphar.2026.1815576 ER -
APA
Z, Y., L, Y., Y, L., D, Y., & Q., Z. (2026). A new era in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): clinical breakthroughs and challenges.. Front Pharmacol. https://doi.org/10.3389/fphar.2026.1815576
Source records
- europe-pmc · retrieved 2026-09-27T01:03:13.729Z
- doaj · retrieved 2026-09-27T01:03:13.736Z